在表面之下:超越染色体DNA突变的新抗原
Shicheng Su1,2,3,4
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Cancer discovery
|November 1, 2024
概括
对于癌症免疫力至关重要的新抗原,可以起源于DNA突变之外. 研究强调转录后和翻译后事件是针对瘤微环境的新型免疫疗法的关键来源.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 传统的理解将新抗原的产生主要归因于染色体DNA突变.
- 新出现的证据表明,转录后和翻译后的修改也产生了重要的新抗原.
- 了解各种新抗原来源对于推进癌症免疫疗法至关重要.
研究的目的:
- 审查已知和潜在的非染色体来源的新抗原.
- 讨论新兴技术用于新抗原的识别和表征.
- 探索研究非染色体新抗原的临床试验,用于下一代癌症免疫疗法.
主要方法:
- 文献综述和综合关于新抗原生成的当前研究.
- 在新抗原发现中分析新兴技术 (例如,转录组学,蛋白质组学).
- 与非染色体新抗原相关的正在进行和已完成的临床试验的概述.
主要成果:
- 包括RNA编辑和蛋白质修饰在内的非染色体事件是新抗原的确定的来源.
- 先进的测序和蛋白质组技术正在提高这些多样化的新抗原的识别.
- 临床试验开始探索基于非DNA突变衍生的新抗原的免疫疗法.
结论:
- 非染色体新抗原是瘤特异性抗原的重要,但经常被忽视的来源.
- 利用这些新抗原可以重新定义瘤免疫性分类 ("热/冷"瘤).
- 这种扩展的理解为更有效和个性化的免疫治疗策略铺平了道路.
相关概念视频
Antigens Involved in Adaptive Immunity
460
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
460
Diversity of Antigen Receptors
527
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
527
Genome Size and the Evolution of New Genes
7.9K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
7.9K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
Exon Recombination
3.6K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...
Exon shuffling follows “splice frame rules.” Each exon...
3.6K


